The Patent Finder

Angiogenetics Sweden AB

Also on record
Records under this name other than patents Angiogenetics Sweden AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Angiogenetics Sweden AB

PatentTitleStatus Expires Confidence
US 7,396,922Regulation of Hypoxia-Inducible Gene Expression with Antisense Inhibitory Pas Domain Protein
Lapsed on the fee record
Ended Jul 8, 2012 · High confidence
Lapsed on the fee recordEnded Jul 8, 2012High confidence
US 7,238,498Screening methods
Lapsed on the fee record
Ended Jul 3, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jul 3, 2011From the USPTO record
US 7,214,770Screening Methods
Lapsed on the fee record
Ended May 8, 2011 · High confidence
Lapsed on the fee recordEnded May 8, 2011High confidence
US 6,436,654Methods for identifying compounds that modulate HIF-1&agr;
Lapsed on the fee record
Ended Aug 20, 2010 · From the USPTO record
Lapsed on the fee recordEnded Aug 20, 2010From the USPTO record
US 5,489,575Polypeptides and their use
Term ended
Term ended no later than Feb 6, 2016 · Low confidence
Term endedTerm ended no later than Feb 6, 2016Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited